INT264626

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 3
Disease Relevance 1.49
Pain Relevance 0.16

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (FCAMR)
FCAMR (Homo sapiens)
Pain Link Frequency Relevance Heat
GABA receptor 15 90.96 High High
gABA 6 83.64 Quite High
agonist 6 58.08 Quite High
Onset of action 3 37.56 Quite Low
Antihistamine 3 21.96 Low Low
antidepressant 6 21.32 Low Low
addiction 3 9.56 Low Low
tolerance 18 9.08 Low Low
alcohol 15 5.00 Very Low Very Low Very Low
depression 12 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Sleep Disorders 183 98.48 Very High Very High Very High
Sleep Initiation And Maintenance Disorders 24 5.00 Very Low Very Low Very Low
Pulmonary Disease 12 5.00 Very Low Very Low Very Low
Depression 9 5.00 Very Low Very Low Very Low
Pain 9 5.00 Very Low Very Low Very Low
Substance Withdrawal Syndrome 6 5.00 Very Low Very Low Very Low
Apnoea 6 5.00 Very Low Very Low Very Low
Anxiety Disorder 6 5.00 Very Low Very Low Very Low
Headache 6 5.00 Very Low Very Low Very Low
Respiratory Failure 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Indiplon was developed in two different formulations to address two different types of insomnia complaint: indiplon-IR (immediate release) was designed for sleep onset difficulties, while indiplon-MR (modified release) was developed for sleep maintenance insomnia.
Localization (release) of indiplon-MR associated with sleep disorders
1) Confidence 0.01 Published 2007 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2656319 Disease Relevance 0.65 Pain Relevance 0.04
Indiplon was developed in two different formulations to address two different types of insomnia complaint: indiplon-IR (immediate release) was designed for sleep onset difficulties, while indiplon-MR (modified release) was developed for sleep maintenance insomnia.
Localization (release) of indiplon-MR associated with sleep disorders
2) Confidence 0.01 Published 2007 Journal Neuropsychiatric Disease and Treatment Section Abstract Doc Link PMC2656319 Disease Relevance 0.53 Pain Relevance 0.05
Indiplon-MR (modified release) was designed to address sleep maintenance difficulties.
Localization (release) of Indiplon-MR
3) Confidence 0.01 Published 2007 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2656319 Disease Relevance 0.32 Pain Relevance 0.07

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox